Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessNutanix (NASDAQ:NTNX) Sees Positive Analyst Ratings and Price Target Increase

Nutanix (NASDAQ:NTNX) Sees Positive Analyst Ratings and Price Target Increase

Add to Favorite
Added to Favorite


Barclays has set a new price target for Nutanix (NASDAQ:NTNX) at $94, indicating a potential upside of 38.13%.
The average brokerage recommendation (ABR) for Nutanix is 1.54, showing a positive sentiment among Wall Street analysts.
Nutanix’s stock price has shown volatility, with a year-high of $75.80 and a low of $43.35, reflecting the dynamic nature of the tech sector.

Nutanix (NASDAQ:NTNX) is a leading cloud computing company that offers enterprise cloud platforms, integrating storage, computing, and virtualization into a comprehensive solution. This simplifies data center operations and positions Nutanix as a competitor to giants like VMware and Dell Technologies in the cloud infrastructure market. Recently, Barclays has recognized Nutanix’s potential, setting a new price target at $94, which suggests a significant upside of 38.13% from its current trading price of $68.05.

Wall Street analysts are bullish on Nutanix, with an average brokerage recommendation (ABR) of 1.54. This rating indicates a strong positive sentiment, as it falls between Strong Buy and Buy. Out of 14 brokerage firms, eight have rated Nutanix as a Strong Buy, while four have given it a Buy rating. These recommendations reflect the analysts’ confidence in the company’s future performance and can influence investor decisions, potentially impacting the stock’s price.

Currently, NTNX is trading at $69.35, marking an increase of 3.63% or $2.43. The stock has experienced fluctuations, with a daily low of $67.39 and a high of $69.85. Over the past year, NTNX has seen a high of $75.80 and a low of $43.35, showcasing the volatility typical of the tech sector, where market sentiment and news can lead to rapid price changes.

Nutanix boasts a market capitalization of approximately $18.58 billion, underscoring its significant role in the cloud computing industry. The company’s stock is actively traded, with a volume of 3,191,936 shares today, indicating strong investor interest and liquidity. This liquidity is crucial for investors, as it allows them to buy and sell shares easily without significantly impacting the stock price.

Subscribe to get Latest News Updates

Latest News

You may like more
more

COPT Defense Properties (NYSE:CDP) Quarterly Earnings Preview

The anticipated EPS of $0.65 for Q1 2025 marks...

Centene Corporation’s Strong Financial Performance in the Healthcare Insurance Industry

Earnings Per Share (EPS) of $2.90, surpassing estimates and...

AbbVie Inc. (NYSE:ABBV) Surpasses Earnings and Revenue Estimates

AbbVie Inc. (NYSE:ABBV) reported an earnings per share (EPS)...